Insmed reported $3.35M in Interest Expense on Debt for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Acelrx Pharmaceuticals ACRX:US USD 247K 80K
Alimera Sciences ALIM:US USD 1.5M 117K
Biomarin Pharmaceutical BMRN:US USD 4.68M 820K
Cytokinetics CYTK:US USD 6.8M 4M
Gilead Sciences GILD:US USD 229M 13M
Insmed INSM:US USD 3.35M 4K
Novartis NVS:US USD 215M 13M
Regeneron Pharmaceuticals REGN:US USD 15.3M 2.2M
Sarepta Therapeutics SRPT:US USD 14.74M 1.29M
Vertex Pharmaceuticals VRTX:US USD 13.7M 900K